Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways

The Lancet. Respiratory Medicine
Simon C RowanP McLoughlin

Abstract

Pulmonary hypertension is a well recognised complication of chronic hypoxic lung diseases, which are among the most common causes of death and disability worldwide. Development of pulmonary hypertension independently predicts reduced life expectancy. In chronic obstructive pulmonary disease, long-term oxygen therapy ameliorates pulmonary hypertension and greatly improves survival, although the correction of alveolar hypoxia and pulmonary hypertension is only partial. Advances in understanding of the regulation of vascular smooth muscle tone show that chronic vasoconstriction plays a more important part in the pathogenesis of hypoxic pulmonary hypertension than previously thought, and that structural vascular changes contribute less. Trials of existing vasodilators show that pulmonary hypertension can be ameliorated and systemic oxygen delivery improved in carefully selected patients, although systemic hypotensive effects limit the doses used. Vasoconstrictor pathways that are selective for the pulmonary circulation can be blocked to reduce hypoxic pulmonary hypertension without causing systemic hypotension, and thus provide potential targets for novel therapeutic strategies.

References

May 29, 1998·American Journal of Respiratory and Critical Care Medicine·R J van SuylenM J Daemen
Aug 3, 1999·American Journal of Respiratory and Critical Care Medicine·H OlschewskiW Seeger
Aug 28, 1999·Respiratory Medicine·T RingbaekK Viskum
Oct 2, 2002·Lancet·Hossein Ardeschir GhofraniFriedrich Grimminger
Feb 4, 2003·The Journal of Physiology·Katherine HowellPaul McLoughlin
Sep 10, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Tetsutaro NagaokaMasahiko Oka
Sep 30, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Christa BoerPieter Sipkema
Jan 28, 2004·Cell·Keith Burridge, Krister Wennerberg
Feb 10, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Jean-Marc HyvelinPaul McLoughlin
Feb 24, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·Karen A FaganIvan F McMurtry
Aug 31, 2004·Journal of Applied Physiology·Robert C MolthenChristopher A Dawson
Nov 2, 2004·American Journal of Respiratory and Critical Care Medicine·Jean-Paul RichaletJérémy Cornolo
Nov 17, 2004·Annals of Internal Medicine·John B WestUNKNOWN American Physiological Society
Feb 8, 2005·American Journal of Physiology. Lung Cellular and Molecular Physiology·John T ReevesKurt R Stenmark
Jun 18, 2005·Circulation Research·Jean-Marc HyvelinPaul McLoughlin
Nov 9, 2005·American Journal of Physiology. Cell Physiology·Chun Y Seow
Sep 30, 2006·Circulation Research·Kurt R StenmarkMaria G Frid
Dec 13, 2006·Circulation Research·George J DimopoulosToshio Kitazawa
Dec 26, 2006·The International Journal of Biochemistry & Cell Biology·Ora Bernard
Mar 16, 2007·Chest·Harold R CollardDavid A Zisman
Apr 25, 2007·American Heart Journal·Mark A LawMichael R Nihill
Nov 21, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·David B FrankMark de Caestecker
Jul 29, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Steven R LammersRobin Shandas
Nov 4, 2008·The European Respiratory Journal·A ChaouatE Weitzenblum
Jul 21, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Scott EarleyJoseph E Brayden
Sep 30, 2009·Respiration; International Review of Thoracic Diseases·Tarek A DernaikaGary T Kinasewitz
Oct 27, 2009·Nature Medicine·Xiaodong LiPatricia A Thistlethwaite
Feb 5, 2010·American Journal of Respiratory and Critical Care Medicine·Connie C W HsiaUNKNOWN ATS/ERS Joint Task Force on Quantitative Assessment of Lung Structure
Feb 12, 2011·The European Respiratory Journal·E FerrerJ A Barberà
Aug 23, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Tadashi YasudaJames West
Dec 31, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Xiao-Ru YangJames S K Sham
Jan 17, 2012·Circulation·Edwina CahillPaul McLoughlin
Feb 3, 2012·The European Respiratory Journal·B KojonazarovA Aldashev
Jun 13, 2012·The Journal of Physiology·Rina Yamin, Kathleen G Morgan
Aug 21, 2012·Trends in Cardiovascular Medicine·Juan Ureña, José López-Barneo
Aug 21, 2012·The European Respiratory Journal·Janne Mykland HildeKjetil Steine
Sep 1, 2012·The European Respiratory Journal·Marius M HoeperJürgen Behr
Sep 4, 2012·The New England Journal of Medicine·J Michael WellsUNKNOWN ECLIPSE Study Investigators
Oct 30, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Yi JinLeif D Nelin

❮ Previous
Next ❯

Citations

May 15, 2016·Seminars in Immunopathology·Gaetano CaramoriIan Adcock
Jun 9, 2016·Current Opinion in Pulmonary Medicine·Sebastian Ley, Julia Ley-Zaporozhan
Sep 1, 2016·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·S D ChaiS J Ma
Apr 5, 2017·High Altitude Medicine & Biology·Colin K Grissom, Barbara E Jones
Jul 4, 2018·Experimental Physiology·Paul McLoughlin
Jun 30, 2019·Acta Cardiologica·Arsene KemdemFlorence Dive
Sep 13, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Yu ZhaoYuguo Chen
Mar 13, 2020·Journal of Receptor and Signal Transduction Research·Juan ChenTao Zhang
Sep 16, 2020·The International Journal of Cardiovascular Imaging·Wei HuaYuehua Fang
Sep 7, 2019·International Journal of Molecular Sciences·Botond SzucsJanos T Varga
Jan 10, 2019·JACC. Basic to Translational Science·Haiyang TangAyako Makino
Apr 23, 2021·Biochemical Pharmacology·Soumeya AbedAnthony F Rullo
Jun 3, 2021·Antioxidants·Daria S Kostyunina, Paul McLoughlin
Oct 20, 2020·Journal of Pharmacological Sciences·Xiangyun GaiXuehua Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.